Advancing innovation in accelerated cancer diagnosis
Funding
Up to £25,400,000
Deadline
Check with the funder
Location
England
Applications
Rolling applications
Overview
Innovate UK is investing up to £25.4 million to support early cancer diagnostic technologies and devices. The funding covers clinical validation and evaluation of these technologies. This grant is part of the OLS Cancer Healthcare Goals programme. The scheme is based in England.
Requirements to check
Who can apply:
Key requirements:
- Must relate to clinical validation or evaluation of early cancer diagnostic technologies or devices
This summary may not include every exclusion. Check the full eligibility rules, including who and what the funder will not support.
This grant is for businesses and researchers in England working on early cancer diagnostic technologies or devices. It focuses on clinical validation and evaluation work. If your work is unrelated to cancer diagnostics, this grant is not for you.
Regions
No published award history for Innovate UK. Some funders do not publish their grants data.
Full details from Innovate UK
Innovate UK, on behalf of the OLS Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.
Loading your grant tools...
Get notified about grants like this
Create a free account to receive alerts when new health & social work funding opens.
Create free accountLast updated: 22 September 2026